Alec Machiels Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 8 hours ago
Alec Machiels has an estimated net worth of at least $15.3 million*, as of Dec. 11, 2024. They own 372,711 shares of APLS stock. They have sold 45,250 shares of APLS stock since 2021, for an estimated $2.4 million.
Alec Machiels $APLS SEC Form 4 Insider Trading
Alec Machiels has filed a total of 29 insider trades in $APLS since 2021. Their most recent trade was a sale of 1,250 shares, made on Nov 17, 2023. Their largest trade was a sale of 3,000 shares, made on Dec 15, 2021. We estimate that they now own 372,711 shares of $APLS, worth an estimated $12.9 million.
Insider Trading at $APLS
There have been a total of 247 insider trades reported at $APLS since 2021, with 250,000 shares purchased and 1.9 million shares sold. The most active insider traders in $APLS stock have been Pascal Deschatelets, Cedric Francois, and Federico Grossi. The most recent trade was a sale of 5,000 shares reported by David O. Watson (General Counsel), made on Dec 11, 2024.
History of Insider Stock Trades by Alec Machiels
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
APLS | Sale | 1,250 | Nov 17, 2023 | Nov. 20, 2023, 5:18 p.m. |
APLS | Sale | 1,250 | Oct 17, 2023 | Oct. 18, 2023, 5:43 p.m. |
APLS | Sale | 1,250 | Sep 18, 2023 | Sept. 19, 2023, 5:05 p.m. |
APLS | Sale | 1,250 | Sep 15, 2023 | Sept. 18, 2023, 4:24 p.m. |
APLS | Sale | 1,250 | Jul 17, 2023 | July 18, 2023, 4:40 p.m. |
APLS | Sale | 1,250 | Jun 20, 2023 | June 21, 2023, 4:34 p.m. |
APLS | Sale | 1,250 | May 17, 2023 | May 18, 2023, 5:12 p.m. |
APLS | Sale | 1,250 | Apr 17, 2023 | April 18, 2023, 4:30 p.m. |
APLS | Sale | 1,250 | Mar 17, 2023 | March 21, 2023, 4:35 p.m. |
APLS | Sale | 1,250 | Feb 17, 2023 | Feb. 21, 2023, 5:22 p.m. |
APLS | Sale | 1,250 | Jan 17, 2023 | Jan. 19, 2023, 5:55 p.m. |
APLS | Sale | 1,250 | Dec 15, 2022 | Dec. 19, 2022, 5:37 p.m. |
APLS | Sale | 1,250 | Nov 15, 2022 | Nov. 17, 2022, 5:33 p.m. |
APLS | Sale | 1,250 | Oct 14, 2022 | Oct. 17, 2022, 5:57 p.m. |
APLS | Sale | 1,250 | Sep 15, 2022 | Sept. 16, 2022, 4:03 p.m. |
APLS | Sale | 1,250 | Aug 15, 2022 | Aug. 16, 2022, 1 p.m. |
APLS | Sale | 1,250 | Jul 15, 2022 | July 18, 2022, 5:29 p.m. |
APLS | Sale | 1,250 | Jun 15, 2022 | June 16, 2022, 8 p.m. |
APLS | Sale | 1,250 | May 16, 2022 | May 17, 2022, 5:26 p.m. |
APLS | Sale | 1,250 | Apr 14, 2022 | April 18, 2022, 7:42 p.m. |
APLS | Sale | 1,250 | Mar 15, 2022 | March 17, 2022, 8:59 p.m. |
APLS | Sale | 1,250 | Feb 15, 2022 | Feb. 16, 2022, 5:29 p.m. |
APLS | Sale | 1,250 | Jan 14, 2022 | Jan. 19, 2022, 9:15 p.m. |
APLS | Sale | 3,000 | Dec 15, 2021 | Dec. 17, 2021, 6:09 p.m. |
APLS | Sale | 3,000 | Nov 15, 2021 | Nov. 16, 2021, 8 p.m. |
APLS | Sale | 3,000 | Nov 04, 2021 | Nov. 16, 2021, 8 p.m. |
APLS | Sale | 2,500 | Aug 16, 2021 | Aug. 16, 2021, 8 p.m. |
APLS | Sale | 2,500 | Jul 15, 2021 | July 15, 2021, 8 p.m. |
APLS | Sale | 2,500 | Jun 15, 2021 | June 15, 2021, 8 p.m. |
$APLS Executives and Stock Owners with Insider Trades
-
Pascal Deschatelets, Chief Scientific Officer
-
Cedric Francois, Chief Executive Officer
-
Federico Grossi, CHIEF MEDICAL OFFICER
-
Adam J. Townsend, Chief Commercial Officer
-
David O. Watson, General Counsel
-
Timothy Eugene Sullivan, Chief Financial Officer
-
Karen Lewis, Chief People Officer
-
Mark Jeffrey Delong, Senior Vice President
-
Lukas Scheibler, CHIEF INNOVATION OFFICER
-
Jeffrey Eisele, Chief Development Officer
-
Nur Nicholson, Chief Technical Officer
-
James George Chopas, VP/Chief Accounting Officer
-
Mark Jeffrey Delong, Chief Business & Strat Officer
-
Nicole D Perry, Vice President - Accounting
-
Federico Grossi, Chief Medical Officer
-
Lukas Scheibler, Chief Research Officer
-
Caroline Baumal, Chief Medical Officer
-
Victoria L. Brown, Program Team Lead
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.